CytoDyn Inc., 2026-05-11
An SEC Form D private-offering notice from Vancouver, WA, a $18,600,392 filer-stated offering target in Biotech. Filed 2026-05-11. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biotechnology company developing leronlimab, a CCR5 targeting monoclonal antibody, for oncology and other therapeutic indications.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Solius Labs, Inc., 2026-05-14, $17.9M, Bainbridge Island, WA
- Niche Biopharmaceuticals LLC, 2026-05-11, $200K, Shorewood, MN
- ROQ LLC, 2026-05-13, $1.6M, Seattle, WA
- Virtuoso Surgical, Inc., 2026-05-11, $10M, Nashville, TN
- Happydahg LLC, 2026-05-12, $1.2M, Redmond, WA
- PANGIA BIOTECH, INC., 2026-05-11, $1.6M, Delray Beach, FL
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.